Ventricular Assist Device and Intra-Aortic Balloon Pump Device Market Size, Share & COVID-19 Impact Analysis | Global | 2021-2027 | MedCore | Includes: Percutaneous VAD Market, Implantable VAD Market, IABP Catheter Market and IABP Console Market

  • Year: 2021
  • Scope: 10 Years
  • Region: Global
  • Type: MedCore

Product Description

This market analysis includes the ventricular assist device (VAD) and the intra-aortic balloon pump device (IABP) markets. The global ventricular assist device (VAD) market size is estimated to increase over the forecast period to reach $3 billion by 2027. The global intra-aortic balloon pump device (IABP) market size is estimated to increase over the forecast period to reach $240.8 million by 2027.

Abiomed, Abbott, and Medtronic were the share leaders in the global ventricular assist device (VAD) market. This global analysis covers over 70 countries, includes in-depth procedure numbers by country, and is segmented into the Percutaneous VAD Market and the Implantable VAD Market. The method for VAD replacement is highly invasive, usually requiring open-heart surgery via a median sternotomy. This will continue to play a limiting role in the widespread adoption and growth of the market.

Getinge and Teleflex were the share leaders in the global intra-aortic balloon pump catheter (IABP) market. This global analysis covers over 70 countries, and in-depth procedure numbers, and is segmented into the IABP Catheter Market and the IABP Console Market. A major limiter to growth in the IABP market is the competition with other product classes.


  • Unit Sales, Average Selling Prices, Market Size & Growth Trends
  • Procedure Numbers
  • COVID-19 Impact Analysis
  • Market Drivers & Limiters
  • Market Forecasts Until 2027, and Historical Data to 2017
  • Recent Mergers & Acquisitions
  • Disease Overviews
  • Company Profiles, Product Portfolios, and SWOT for Top Competitors

Procedure Numbers

procedure numbers by country for mechanical and tissue heart valves including the aortic, mitral, pulmonary, and tricuspid procedures

Procedure numbers for both the global ventricular assist device (VAD) market and the global intra-aortic balloon pump catheter (IABP) market are included. VAD procedures are further broken down into percutaneous VAD and implantable VAD procedures. Within this report, the procedure numbers are segmented by country and include an in-depth analysis utilizing historical data from 2017 and market forecasts into 2027.

Ventricular Assist Device Market Insights

The global market for VADs is divided into two segments: Percutaneous VAD Market and the Implantable VAD Market. The pVAD market includes devices used in the left and right hearts. Percutaneous VADs (pVADs) are a specific type of VAD with different designs and use from implantable VADs. The implantable VAD market comprises implantable VADs and extracorporeal BiVADs.The pVAD segment is growing much more rapidly than the implantable VAD segment and is expected to increase its share of the total VAD market by the end of the forecast period.ventricular assist device global market analysis

Intra-Aortic Balloon Pump Catheter Market Insights

Growth in the disposable IABP devices market will be driven by the increasing penetration rate of fiber-optic IABP catheters. Fiber-optic IABP catheters use more advanced technology than conventional IABP catheters and command a higher ASP. The increasing popularity of PCI procedures will make a positive contribution to IABP catheter unit sales. Similarly, PCI procedures and replacement sales will drive growth. Overall, IABP catheter ASPs will offset the decline in unit sales over the forecast period.Intra-Aortic Balloon Pump Catheter Global Market Analysis from 2017-2027


The global Intra-Aortic Balloon and Ventricular Assist markets are controlled by Abiomed, Abbott, Medtronic, Getinge, and market share leaders in the VAD and IABP markets Getinge was the leading competitor in the IABP device market in 2020. Getinge offers multiple IABP consoles, including the CARDIOSAVE® IABP Hybrid, CARDIOSAVE® IABP Rescue, CS100 IABP with Intellisence™, and CS300 IABP. Abiomed was the market leader in the global VAD market in 2020. Abiomed specializes in pVADs with its line of Impella products.


Throughout this report, iData Research has covered over 70 countries across the globe in great detail. Each global region may be purchased as a stand-alone report, tailoring the data to your needs. The regions covered are:

  • North America (the United States and Canada)
  • Latin America (Brazil, Mexico, Colombia, Argentina, Peru, Chile, Venezuela, and Other)
  • Western Europe (Germany, France, Italy, Spain, Switzerland, Austria, Portugal, Benelux, Scandinavia, and Other)
  • Central and Eastern Europe (Poland, Turkey, Russia, Greece, Czech Republic, Croatia, Bulgaria, Ukraine, Kazakhstan, Hungary, Romania, Baltic States (Estonia, Latvia, and Lithuania), and Other)
  • Middle East (Saudi Arabia, UAE, Israel, Iran, Kuwait, Qatar, Bahrain, Oman, and Other)
  • Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Indonesia, Malaysia, Thailand, the Philippines, Brunei, Myanmar, Cambodia, Vietnam, New Zealand, Taiwan, Hong Kong, and Other)
  • Africa South Africa, Egypt, Morocco, Ghana, Nigeria, Libya, Sudan, Uganda, Kenya, and Other)


FREE Sample Report

For a detailed table of contents, please contact an iData Research Product Advisor.
Companies Included: Abiomed, Abbott, Medtronic, LivaNova, Getinge, Teleflex, Others

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Explore Options

Report Summary


Select License Type

Ventricular assist devices (VADs) are used to aid a failing heart by supplementing the pumping function of the heart. VADs are often used in patients with advanced heart failure (HF). HF is a chronic disease that occurs when degeneration of the heart muscle reduces the pump power of the heart, which causes the heart to become too weak to pump blood at a level sufficient to meet the body’s demands.

  • 2021
  • 10 Years
  • Global
  • MedCore
    Your Cart
    Your cart is emptyReturn to Report Library